TASCENSO ODT
These highlights do not include all the information needed to use TASCENSO ODT™ safely and effectively. See full prescribing information for TASCENSO ODT. TASCENSO ODT (fingolimod) orally disintegrating tablets Initial U.S. Approval: 2010
bf8e7f89-ea09-43c7-a7eb-e44724350721
HUMAN PRESCRIPTION DRUG LABEL
Aug 17, 2023
Cycle Pharmaceuticals Ltd
DUNS: 218215530
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Fingolimod Lauryl Sulfate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
Fingolimod Lauryl Sulfate
Product Details
FDA regulatory identification and product classification information